Evidence map›Paper›PMID 20581741›Full record

ArticlePediatric research2010

Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.

Nahid Waleh, Ryan Hodnick, Nami Jhaveri, Suzanne McConaghy, John Dagle, Steven Seidner, Donald McCurnin, Jeffrey C Murray, Robin Ohls, Ronald I Clyman

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03022253 (Liberal Versus Restrictive Platelet Transfusion for Treatment of Hemodynamically Significant Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates- A Randomized Open Label, Controlled Trial), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03022253 phase3completednot on this mapstarted 2016, after this paper: background citation

Liberal Versus Restrictive Platelet Transfusion for Treatment of Hemodynamically Significant Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates- A Randomized Open Label, Controlled Trial

TypeinterventionalSponsorPost Graduate Institute of Medical Education and Research, ChandigarhRan2016 to 2017Enrolled44ConditionsPatent Ductus ArteriosusArmsLiberal platelet transfusion, Restrictive platelet transfusion, Paracetamol, Ibuprofen
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Mouse models of patent ductus arteriosus (PDA) and their relevance for human PDA.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Review
  4. Review
  5. Review
  6. Genetic variants associated with patent ductus arteriosus in extremely preterm infants.Journal of perinatology : official journal of the California Perinatal Association · 2019
    Article
  7. Article
  8. Review
  9. Review
  10. Response to Coceani et al.Pediatric research · 2017
    Article
  11. Article
  12. Article
  13. Predictors of successful closure of patent ductus arteriosus with indomethacin.Journal of perinatology : official journal of the California Perinatal Association · 2015
    Observational
  14. DLG5 in cell polarity maintenance and cancer development.International journal of biological sciences · 2014
    Review
  15. Article
  16. Current Perspectives on Pathobiology of the Ductus Arteriosus.Journal of clinical & experimental cardiology · 2012
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Nahid WalehPharmaceutical Discovery Division, SRI International, Menlo Park, California 94025, USA.
Ryan Hodnick
Nami Jhaveri
Suzanne McConaghy
John Dagle
Steven Seidner
Donald McCurnin
Jeffrey C Murray
Robin Ohls
Ronald I Clyman
University of New Mexico · USThe University of Texas Health Science Center at San Antonio · USUniversity of California, San Francisco · USUniversity of Iowa · USSRI International · US

Funding

WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI GAUDUIN, MARIE-CLAIRE ELISABETH · 1999 to 2011
$79.1M
COLLABORATIVE PROGRAM IN BPDU01HL052636 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI COALSON, JACQUELINE JONES · 1999 to 2007
$18.1M
VESSEL REMODELING DURING FETAL DUCTUS ARTERIOSUS CLOSURER01HL046691 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CLYMAN, RONALD I · 1992 to 2010
$3.9M
Maternal and fetal genetic factors in preterm birthR01HD052953 · NICHD · UNIVERSITY OF IOWA · PI MURRAY, JEFFREY C · 2006 to 2010
$2.8M
REGULATION OF THE DUCTUS ARTERIOSUSU01HL056061 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CLYMAN, RONALD I · 1999 to 2006
$1.8M
A Family and Population Approach to Gene Discovery for Preterm BirthR01HD057192 · NICHD · UNIVERSITY OF IOWA · PI MURRAY, JEFFREY C · 2009 to 2011
$1.8M
REGULATION OF THE DUCTUS ARTERIOSUSU10HL056061 · NHLBI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI CLYMAN, RONALD I · 1995 to 1998
–
COLLABORATIVE PROGRAM IN BPDR10HL052636 · NHLBI · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI COALSON, JACQUELINE JONES · 1994 to 1994
–
COLLABORATIVE PROGRAM IN BPDU10HL052636 · NHLBI · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI COALSON, JACQUELINE JONES · 1994 to 1998
–
NCRR NIH HHS P51 RR013986NCRR NIH HHS P51RR13986NHLBI NIH HHS HL46691NHLBI NIH HHS HL52636NHLBI NIH HHS HL56061NHLBI NIH HHS R01 HL046691NHLBI NIH HHS U01 HL052636NHLBI NIH HHS U01 HL056061NICHD NIH HHS HD52953NICHD NIH HHS R01 HD052953NICHD NIH HHS R01 HD057192
6 · The paper itself

Abstract

Three independent risk factors (immature gestation, absence of antenatal glucocorticoid exposure, and presence of the rs2817399(A) allele of the gene TFAP2B) are associated with patent ductus arteriosus (PDAs) that fail to close during prostaglandin inhibition. We hypothesized that these three factors may affect a common set of genes that increase the risk of persistent PDA after birth. We studied baboon ductus from term, preterm, and glucocorticoid-treated preterm fetuses and found that both immature gestation and absence of antenatal glucocorticoid exposure decreased RNA expression of calcium- and potassium-channel genes involved in oxygen-induced constriction, and phosphodiesterase genes (that modulate cAMP/cGMP signaling). Ductus obtained from second trimester human pregnancies were genotyped for TFAP2B polymorphisms. When present, the rs2817399(A) allele also was associated with decreased expression of calcium- and potassium-channel genes. In contrast, alleles of two other TFAP2B polymorphisms, rs2817419(G) and rs2635727(T), which are not related to the incidence of PDA after birth, had no effect on RNA expression. In conclusion, three calcium- and potassium-channel genes (CACNA1G/ alpha1G, CACNB 2/CaL-beta2, and KCNA2/ Kv1.2) were similarly affected by each of the PDA risk factors. We speculate that these channels may play a significant role in closing the preterm ductus during prostaglandin inhibition and may be potential targets for future pharmacologic manipulations.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsCalcium Channels, L-TypeCalcium Channels, T-TypeDrug Administration ScheduleDuctus ArteriosusDuctus Arteriosus, PatentFemaleGenetic Predisposition to DiseaseGestational AgeGlucocorticoidsHumansKv1.2 Potassium ChannelLinear ModelsLogistic ModelsPapioCACNA1G protein, humanCACNB2 protein, humanCalcium Channels, L-TypeCalcium Channels, T-TypeGlucocorticoidsKCNA2 protein, humanKv1.2 Potassium ChannelRNA, Messenger

Identifiers

PMID20581741
PMCPMC2940964
OpenAlexW1994049731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.